Literature DB >> 11749865

Relationship between lactone ring forms of HCPT and their antitumor activities.

J J Zhou1, J Liu, B Xu.   

Abstract

AIM: To study the relationship between the lactone forms of 10-hydroxycamptothecin (HCPT) and their antitumor activities.
METHODS: Antitumor activity of the two forms of HCPT was studied in vitro using seven cultured human and mouse tumor cell lines. Mice bearing sarcoma 180 and solid hepatoma were treated with HCPT (0.5, 1, and 2 mg/kg, ip) and tumor growth inhibition was assayed. HPLC method was employed to investigate the conversion of two forms of HCPT in different pH conditions and cultured tumor cells.
RESULTS: It was found that both forms of HCPT (O-HCPT and C-HCPT) showed similar activities in vitro against a number of tumor cell lines at the same concentration; but C-HCPT was more effective (about two times) than O-HCPT in vivo. The difference between in vitro and in vivo results could be explained by the conversion of O-HCPT into C-HCPT in a certain condition, which was shown by the HPLC analysis of HCPT at different pH values and in cultured tumor cells.
CONCLUSION: Both forms of HCPT were effective against tumor growth, but C-HCPT was more effective than O-HCPT, the latter could be converted into the former under certain conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11749865

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  8 in total

1.  Evaluation of HCPTd1,d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma.

Authors:  Zhi-Jian Yu; Jia-Wei Yu; Wei Cai; Hong-Xin Yuan; Xiao-Yan Li; Ye Yuan; Jian-Ping Chen; Xiao-Yin Wu; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

2.  A novel camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo.

Authors:  Min Han; Cai-Xia He; Qiu-Li Fang; Xiao-Chun Yang; Yuan-Yuan Diao; Dong-Hang Xu; Qiao-Jun He; Yong-Zhou Hu; Wen-Quan Liang; Bo Yang; Jian-Qing Gao
Journal:  Pharm Res       Date:  2008-12-02       Impact factor: 4.200

3.  Assessing the regioselectivity of OleD-catalyzed glycosylation with a diverse set of acceptors.

Authors:  Maoquan Zhou; Adel Hamza; Chang-Guo Zhan; Jon S Thorson
Journal:  J Nat Prod       Date:  2013-01-29       Impact factor: 4.050

4.  Preclinical Evaluation and Monitoring of the Therapeutic Response of a Dual Targeted Hyaluronic Acid Nanodrug.

Authors:  Minglong Chen; Wenqi Zhang; Kai Yuan; Mingxiang Bo; Bin Chen; Lu Li; Qingjie Ma; Lei Zhu; Shi Gao
Journal:  Contrast Media Mol Imaging       Date:  2017-07-11       Impact factor: 3.161

5.  A Multifunctional Nanotherapy for Targeted Treatment of Colon Cancer by Simultaneously Regulating Tumor Microenvironment.

Authors:  Qixiong Zhang; Fuzhong Zhang; Shanshan Li; Renfeng Liu; Taotao Jin; Yin Dou; Zhenhua Zhou; Jianxiang Zhang
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

6.  Characterization of DNA topoisomerase-1 in Spodoptera exigua for toxicity evaluation of camptothecin and hydoxy-camptothecin.

Authors:  Lan Zhang; Dejun Ma; Yanning Zhang; Weizhi He; Jingjing Yang; Chuanren Li; Hongyun Jiang
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

7.  Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect.

Authors:  Anxun Wang; Su Li
Journal:  BMC Biotechnol       Date:  2008-05-04       Impact factor: 2.563

Review 8.  Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugs.

Authors:  Antonella Accardo; Luigi Aloj; Michela Aurilio; Giancarlo Morelli; Diego Tesauro
Journal:  Int J Nanomedicine       Date:  2014-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.